Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
PaperCitations, authors & open-access status
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,702 citations, 2021 year and closed oa status.
1,702
Citations
2021
Year
closed
OA Status